ANTHONY W OPIPARI, MD
Medical Practice in Ann Arbor, MI
License number
Michigan 4301063648
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
1500 Floor Cancer & Geriatrics Ct, Ann Arbor, MI 48109
Phone
(734) 647-8906
(734) 936-2047
(734) 936-2047
Personal information
See more information about ANTHONY W OPIPARI at radaris.comName
Address
Phone
2973 Stonewater Way, Dexter, MI 48130
4228 Sherwood Forest Ct, Ann Arbor, MI 48103
2816 Wylie Rd, Dexter, MI 48130
Dexter, MI
2973 Stonewater Way, Dexter, MI 48130
Professional information
Dr. Anthony W Opipari, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Obstetrics & Gynecology
Address:
1500 E Medical Center Dr SUITE 5902, Ann Arbor 48109
(734) 647-8906 (Phone), (734) 764-7261 (Fax)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-8906 (Phone), (734) 764-7261 (Fax)
1500 E Medical Center Dr, Ann Arbor 48109
Certifications:
Obstetrics & Gynecology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr SUITE 5902, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
University Of Michigan Medical School
Graduated: 1994
University Of Mi Hosps and Health Ctrs
University Of Michigan Medical School
Graduated: 1994
University Of Mi Hosps and Health Ctrs
Anthony W Opipari, Ann Arbor MI
Specialties:
OB-GYN
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Doctor of Medicine
Board certifications:
American Board of Obstetrics and Gynecology Certification in Obstetrics & Gynecology
Anthony William Opipari, Ann Arbor MI
Specialties:
Obstetrics & Gynecology, Gynecology, Obstetrics
Work:
University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Michigan Medical School (1994)
Therapeutic Application Of Pro-Apoptotic Benzodiazepines
US Patent:
2001001, Aug 23, 2001
Filed:
Jan 22, 2001
Appl. No.:
09/767283
Inventors:
Gary D. Glick - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
International Classification:
A61K031/5513
US Classification:
514/220000
Abstract:
Benzodiazepine compounds, and methods for using those compounds are provided. Some of the benzodiazepine compounds include 1,4-benzodiazepine-2-one and 1,4-benzodiazepine-2,5-dione compounds of the following structures:
wherein R, R, Rand Rare as defined. The invention also includes enantiomers, pharmaceutically acceptable salts, prodrugs or derivatives of the benzodiazepine compounds. Any one or more of these benzodiazepine compounds can be used to treat a variety of dysregulatory disorders related to cellular death. Such disorders include autoimmune disorders, inflammatory conditions, hyperproliferative conditions, viral infections, and atherosclerosis. In addition, the above compounds can be used to prepare medicaments to treat the above-described dysregulatory disorders. The benzodiazepines can also be used in drug screening assays and other diagnostic methods.
Therapeutic Applications Of Pro-Apoptotic Benzodiazepines
US Patent:
2007003, Feb 15, 2007
Filed:
Oct 23, 2006
Appl. No.:
11/585492
Inventors:
Gary Glick - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
International Classification:
A61K 31/5513, A61K 9/20
US Classification:
424464000, 514221000
Abstract:
Benzodiazepine compounds, and methods for using those compounds are provided. Some of the benzodiazepine compounds include 1,4-benzodiazepine-2-one and 1,4-benzodiazepine-2,5-dione compounds of the following structures:
wherein R, R, Rand Rare as defined. The invention also includes enantiomers, pharmaceutically acceptable salts, prodrugs or derivatives of the benzodiazepine compounds. Any one or more of these benzodiazepine compounds can be used to treat a variety of dysregulatory disorders related to cellular death. Such disorders include autoimmune disorders, inflammatory conditions, hyperproliferative conditions, viral infections, and atherosclerosis. In addition, the above compounds can be used to prepare medicaments to treat the above-described dysregulatory disorders. The benzodiazepines can also be used in drug screening assays and other diagnostic methods.
Compositions And Methods Relating To Novel Benzodiazepine Compounds And Targets Thereof
US Patent:
2003011, Jun 26, 2003
Filed:
Aug 13, 2002
Appl. No.:
10/217878
Inventors:
Gary Glick - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K031/5513, C12Q001/68, A61K031/55, A01N043/62, C12N007/00, C12N007/01, C12N005/00, C12N005/02
US Classification:
435/006000, 514/221000, 435/235100, 435/325000
Abstract:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
Compositions And Methods Relating To Novel Compounds And Targets Thereof
US Patent:
2005026, Nov 24, 2005
Filed:
May 1, 2003
Appl. No.:
10/427211
Inventors:
Gary Glick - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K038/17
US Classification:
514012000
Abstract:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
Compostions And Methods Relating To Novel Compounds And Targets Thereof
US Patent:
2007029, Dec 27, 2007
Filed:
May 25, 2007
Appl. No.:
11/807291
Inventors:
Gary Glick - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
Anthony Opipari - Ann Arbor MI, US
International Classification:
A61K 31/55, A61P 43/00, C07D 243/12
US Classification:
514221000, 540504000
Abstract:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
Compositions And Methods For Inhibiting The Proliferation Of Cells
US Patent:
2013019, Jul 25, 2013
Filed:
Dec 17, 2012
Appl. No.:
13/717096
Inventors:
Gary D. Glick - Ann Arbor MI, US
Anthony W. Opipari - Ann Arbor MI, US
Anthony W. Opipari - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C07D 243/24
US Classification:
514221, 540504
Abstract:
The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
Compositions And Methods For Inhibiting The Proliferation Of Cells
US Patent:
8415343, Apr 9, 2013
Filed:
Dec 21, 2006
Appl. No.:
11/643614
Inventors:
Gary D. Glick - Ann Arbor MI, US
Anthony W. Opipari - Ann Arbor MI, US
Anthony W. Opipari - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 31/55, A61K 31/59, A61K 31/05
US Classification:
514221, 514167, 514731
Abstract:
The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.